KRYS
Krystal Biotech, Inc.
Stock
$322.28−3.03 (−0.93%)Close Oct 2, 2026
- Operating cash flow, 2025
- $201M
- YoY, 2025
- +62.7%
Operating cash flow
Operating cash flow by fiscal year
| Period | Operating cash flow | YoY |
|---|---|---|
| 2025 | $201M | +62.7% |
| 2024 | $123M | — |
| 2023 | −$89M | — |
| 2022 | −$101M | — |
| 2021 | −$48M | — |
| 2020 | −$26M | — |
| 2019 | −$19M | — |
| 2018 | −$9.4M | — |
| 2017 | −$3.9M | — |
| 2016 | −$1.3M | — |